Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Verheugt, F.W."'
Autor:
McElhaney, J.E., Beran, J., Devaster, J.M., Esen, M., Launay, O., Leroux-Roels, G., Ruiz-Palacios, G.M., Essen, G.A. van, Caplanusi, A., Claeys, C., Durand, C., Duval, X., Idrissi, M. El, Falsey, A.R., Feldman, G., Frey, S.E., Galtier, F., Hwang, S.J., Innis, B.L., Kovac, M., Kremsner, P., McNeil, S., Nowakowski, A., Richardus, J.H., Trofa, A., Oostvogels, L., Verheugt, F.W.
Publikováno v:
Lancet Infectious Diseases, 13(6), 485-496. Lancet Publishing Group
Lancet Infectious Diseases, 13, 485-96
Lancet Infectious Diseases, 13, 6, pp. 485-96
Lancet Infectious Diseases, 13, 485-96
Lancet Infectious Diseases, 13, 6, pp. 485-96
Item does not contain fulltext BACKGROUND: We aimed to compare AS03-adjuvanted inactivated trivalent influenza vaccine (TIV) with non-adjuvanted TIV for seasonal influenza prevention in elderly people. METHODS: We did a randomised trial in 15 countri
Autor:
Bhatt, D.L., Stone, G.W., Mahaffey, K.W., Gibson, C.M., Steg, P.G., Hamm, C.W., Price, M.J., Leonardi, S., Gallup, D., Bramucci, E., Radke, P.W., Widimsky, P., Tousek, F., Tauth, J., Spriggs, D., McLaurin, B.T., Angiolillo, D.J., Genereux, P., Liu, T., Prats, J., Todd, M., Skerjanec, S., White, H.D., Harrington, R.A., Verheugt, F.W.
Publikováno v:
The New England Journal of Medicine, 368, 14, pp. 1303-13
The New England Journal of Medicine, 368, 1303-13
New England journal of medicine, 368(14), 1303-1313. Massachussetts Medical Society
The New England Journal of Medicine, 368, 1303-13
New England journal of medicine, 368(14), 1303-1313. Massachussetts Medical Society
Item does not contain fulltext BACKGROUND: The intensity of antiplatelet therapy during percutaneous coronary intervention (PCI) is an important determinant of PCI-related ischemic complications. Cangrelor is a potent intravenous adenosine diphosphat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da3c0ed98051b54907ae48ab9dd4ecc1
https://hdl.handle.net/2066/119266
https://hdl.handle.net/2066/119266
Autor:
Steg, G., James, S.K., Atar, D., Badano, L.P., Blomstrom-Lundqvist, C., Borger, M.A., Mario, C. de, Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A.H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M.J., Mahaffey, K.W., Valgimigli, M., Hof, A. van't, Widimsky, P., Zahger, D., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Kirchhof, P., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., Sectem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Astin, F., Astrom, A.K., Budaj, A., Clemmensen, P., Collet, J.P., Fox, K.A., Fuat, A., Gustiene, O., Hamm, C.W., Kala, P., Lancellotti, P., Pietro Maggioni, A., Merkely, B., Neumann, F.J., Piepoli, M., Werf, F. van de, Verheugt, F.W., Wallentin, L.
Publikováno v:
Revista Espanõla de Cardiología, 66, 53 e1-53 e46
Revista Espanõla de Cardiología, 66, 1, pp. 53 e1-53 e46
Revista Espanõla de Cardiología, 66, 1, pp. 53 e1-53 e46
Contains fulltext : 119289.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7e6dc1d2fc7cd105b667e86480308f9d
http://hdl.handle.net/2066/119289
http://hdl.handle.net/2066/119289
Publikováno v:
American Heart Journal, 155(6), 1039-1046
American Heart Journal, 155, 1039-46
American Heart Journal, 155, 6, pp. 1039-46
Brouwer, M A, Kievit, P C, Dieker, H J, Veen, G, Karreman, A J & Verheugt, F W 2008, ' Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial ', American Heart Journal, vol. 155, no. 6, pp. 1039-1046 . https://doi.org/10.1016/j.ahj.2008.01.008
American Heart Journal, 155, 1039-46
American Heart Journal, 155, 6, pp. 1039-46
Brouwer, M A, Kievit, P C, Dieker, H J, Veen, G, Karreman, A J & Verheugt, F W 2008, ' Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial ', American Heart Journal, vol. 155, no. 6, pp. 1039-1046 . https://doi.org/10.1016/j.ahj.2008.01.008
Contains fulltext : 70887.pdf (Publisher’s version ) (Closed access) BACKGROUND: Whether late coronary patency after myocardial infarction has prognostic impact independent of left ventricular function remains a matter of debate. Reocclusion rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d396d0ce858d1352b2bdd311d23822d0
https://research.vumc.nl/en/publications/b39b24b8-f7ed-418a-b05a-9aa3f4b716ca
https://research.vumc.nl/en/publications/b39b24b8-f7ed-418a-b05a-9aa3f4b716ca
Autor:
Curtis, J.P., Alexander, J.H., Huang, Y., Wallentin, L., Verheugt, F.W., Armstrong, P.W., Krumholz, H.M., Van de Werf, F., Danays, T., Cheeks, M., Granger, A.M., ASSENT-2 and ASSENT-3 Investigators (Husted, S.E.)
Publikováno v:
Curtis, J P, Alexander, J H, Huang, Y, Wallentin, L, Verheugt, F W, Armstrong, P W, Krumholz, H M, Van de Werf, F, Danays, T, Cheeks, M, Granger, A M & ASSENT-2 and ASSENT-3 Investigators (Husted, S E 2004, ' Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from assessment of the safety and efficacy of a new thrombolytic regimens 2 and 3) ' Am. J. Cardiol, vol. 94, pp. 279-283 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::424666da1f21fae866648f4014aa4390
https://pure.au.dk/portal/da/publications/efficacy-and-safety-of-two-unfractionated-heparin-dosing-strategies-with-tenecteplase-in-acute-myocardial-infarction-results-from-assessment-of-the-safety-and-efficacy-of-a-new-thrombolytic-regimens-2-and-3(c6859e30-fd1f-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/efficacy-and-safety-of-two-unfractionated-heparin-dosing-strategies-with-tenecteplase-in-acute-myocardial-infarction-results-from-assessment-of-the-safety-and-efficacy-of-a-new-thrombolytic-regimens-2-and-3(c6859e30-fd1f-11da-bee9-02004c4f4f50).html
Autor:
Dubois, C.L., Belmans, A., Granger, C.B., Armstrong, P.W., Wallentin, L., Fioretti, P.M., Lopez-Sendon, J.L., Verheugt, F.W., Meyer, J., Van de Werf, F., ASSENT-3 Investigators (S.E. Husted)
Publikováno v:
Dubois, C L, Belmans, A, Granger, C B, Armstrong, P W, Wallentin, L, Fioretti, P M, Lopez-Sendon, J L, Verheugt, F W, Meyer, J, Van de Werf, F & ASSENT-3 Investigators (S.E. Husted) 2003, ' Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab ' Journal of the American College of Cardiology, vol. 42, pp. 1178-1185 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::cc26e080683b0cf20ab4ff4c4723b209
https://pure.au.dk/portal/da/publications/outcome-of-urgent-and-elective-percutaneous-coronary-interventions-after-pharmacologic-reperfusion-with-tenecteplase-combined-with-unfractionated-heparin-enoxaparin-or-abciximab(613004f0-b812-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/outcome-of-urgent-and-elective-percutaneous-coronary-interventions-after-pharmacologic-reperfusion-with-tenecteplase-combined-with-unfractionated-heparin-enoxaparin-or-abciximab(613004f0-b812-11da-bee9-02004c4f4f50).html
Autor:
Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D.V., Falk, E., Fox, K.A., Julian, D., Lengyel, M., Neumann, F.J., Ruzyllo, W., Thygesen, C., Underwood, S.R., Vahanian, A., Verheugt, F.W., Wijns, W., nullForceontheManagementofAcuteMyocardialInfarctionoftheEuropeanSocietyofCardiology, Task
Publikováno v:
Van de Werf, F, Ardissino, D, Betriu, A, Cokkinos, D V, Falk, E, Fox, K A, Julian, D, Lengyel, M, Neumann, F J, Ruzyllo, W, Thygesen, C, Underwood, S R, Vahanian, A, Verheugt, F W, Wijns, W & nullForceontheManagementofAcuteMyocardialInfarctionoftheEuropeanSocietyofCardiology, T 2003, ' Management of Acute myocardial infarction in patients presenting with segment elevation. The Task Force on the Management of Acute Myocardial Infarction of theEuropean Society of Cardiology ', European Heart Journal, vol. 24, no. 1, pp. 28-66 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::b0dade350c0e2baaa1d08b1f795df919
https://pure.au.dk/portal/da/publications/management-of-acute-myocardial-infarction-in-patients-presenting-with-segment-elevation-the-task-force-on-the-management-of-acute-myocardial-infarction-of-theeuropean-society-of-cardiology(054735a0-9841-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/management-of-acute-myocardial-infarction-in-patients-presenting-with-segment-elevation-the-task-force-on-the-management-of-acute-myocardial-infarction-of-theeuropean-society-of-cardiology(054735a0-9841-11da-bee9-02004c4f4f50).html
Autor:
Dubois, C.L., Belmans, A., Granger, C.B., Amstrong, P.W., Wallentin, L., nullP.M., Fioretti, Lopez-Sendon, J.L., Verheugt, F.W., Meyer, J., Van de Werf, F., ASSENT-3 Investigators (Husted, S.E.)
Publikováno v:
Dubois, C L, Belmans, A, Granger, C B, Amstrong, P W, Wallentin, L, nullP.M., F, Lopez-Sendon, J L, Verheugt, F W, Meyer, J, Van de Werf, F & ASSENT-3 Investigators (Husted, S E 2003, ' Outcome of urgent and elective percutaneous coronary interventions after pharmacologic with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab ' Journal of the American College of Cardiology, vol. 42, pp. 1178-1185 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::58441fd39f851cd0764813397f4ad6d5
https://pure.au.dk/portal/da/publications/outcome-of-urgent-and-elective-percutaneous-coronary-interventions-after-pharmacologic-with-tenecteplase-combined-with-unfractionated-heparin-enoxaparin-or-abciximab(3b2fd4f0-b8db-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/outcome-of-urgent-and-elective-percutaneous-coronary-interventions-after-pharmacologic-with-tenecteplase-combined-with-unfractionated-heparin-enoxaparin-or-abciximab(3b2fd4f0-b8db-11da-bee9-02004c4f4f50).html
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 158, 0, pp. A7609
Nederlands Tijdschrift voor Geneeskunde, 158, A7609
Nederlands Tijdschrift voor Geneeskunde, 158, A7609
Item does not contain fulltext - Platelet aggregation inhibitors reduce the risk of complications during and after acute coronary syndromes and after a TIA or stroke.- Acetylsalicylic acid plays a major role in secondary prevention; the combination o
Autor:
Camm, A.J., Lip, G.Y., Caterina, R.D., Savelieva, I., Atar, D., Hohnloser, S.H., Hindricks, G., Kirchhof, P., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., Sechtem, U., Anton Sirnes, P., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Vardas, P., Al-Attar, N., Alfieri, O., Angelini, A., Blomstrom-Lundqvist, C., Colonna, P., Sutter, J. de, Ernst, S.M.P.G., Goette, A., Gorenek, B., Hatala, R., Heidbuchel, H., Heldal, M., Dalby Kristensen, S., Heuzey, J.Y., Mavrakis, H., Mont, L., Perrone Filardi, P., Ponikowski, P., Prendergast, B., Rutten, F.H., Schotten, U., Gelder, I.C van, Verheugt, F.W.
Publikováno v:
Revista Espanõla de Cardiología, 66, 1, pp. 54.e1-54.e24
Revista Espanõla de Cardiología, 66, 54.e1-54.e24
Revista Espanõla de Cardiología, 66, 54.e1-54.e24
Contains fulltext : 119158.pdf (Publisher’s version ) (Closed access)